8604:TSENomura Holdings, Inc. Analysis
Data as of 2026-07-17 - not real-time
¥1,518.00
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Nomura Holdings (8604.T) is trading at ¥1,518, comfortably above its 20‑day (¥1,488), 50‑day (¥1,389) and 200‑day (¥1,283) moving averages, confirming a bullish technical backdrop. The RSI sits at 56, indicating neither overbought nor oversold conditions, while the MACD histogram is positive (+3.65) and the signal line is bullish, reinforcing upward momentum. Volume is on an increasing trend, and the price is holding above the identified support of ¥1,396 with upside potential toward the resistance at ¥1,636, implying an estimated 9% gain to the median analyst target of ¥1,665. Fundamentally, the stock trades at a forward PE of 16.7 versus an industry average of 18.0, and a price‑to‑book of 1.19, suggesting it is modestly undervalued relative to peers. Revenue growth of 27.5% and robust gross (78%) and operating margins (19.5%) underscore strong earnings quality, though operating cash flow is negative and the debt‑to‑equity ratio exceeds 900, flagging balance‑sheet stress. The dividend yield of 3.17% with a 43% payout ratio appears sustainable given the substantial cash reserves, even as free cash flow is currently zero. Volatility is elevated at 32.7% over the past 30 days, but beta remains below 1 (≈0.8), indicating limited market‑wide sensitivity. The market sentiment is in the “Extreme Greed” zone (Fear & Greed Index 91.55), which may be inflating short‑term enthusiasm. Overall, the stock presents a blend of growth drivers and value attributes, but investors should monitor cash‑flow generation and leverage levels.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Bullish MACD and price above all major SMAs
- Increasing volume supporting momentum
- Support level comfortably held at ¥1,396
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Undervalued PE relative to industry peers
- Strong revenue growth and healthy dividend yield
- Target price upside of roughly 9% to analyst median
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Sustainable dividend but high debt‑to‑equity ratio
- Negative operating cash flow raises cash‑flow risk
- Stable earnings margins and solid market position in capital markets
Key Metrics & Analysis
Financial Health
Revenue Growth27.50%
Profit Margin16.71%
P/E Ratio12.7
ROE10.07%
ROA0.63%
Debt/Equity984.20
P/B Ratio1.2
Op. Cash Flow¥-842960011264
Industry P/E18.0
Technical Analysis
TrendBullish
RSI56.2
Support¥1,396.00
Resistance¥1,636.00
MA 20¥1,488.23
MA 50¥1,387.97
MA 200¥1,283.11
MACDBullish
VolumeIncreasing
Fear & Greed Index91.55
Valuation
Target Price¥1,653.75
Upside/Downside8.94%
GradeUndervalued
TypeBlend
Dividend Yield3.17%
Risk Assessment
Beta0.80
Volatility32.66%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.